TY - JOUR
T1 - Neonatal vitamin D status is not associated with later risk of type 1 diabetes
T2 - results from two large Danish population-based studies
AU - Jacobsen, Ramune
AU - Thorsen, Steffen Ullitz
AU - Cohen, Arieh S
AU - Lundqvist, Marika
AU - Frederiksen, Peder
AU - Pipper, Christian Bressen
AU - Pociot, Flemming
AU - Thygesen, Lau Caspar
AU - Ascherio, Alberto
AU - Svensson, Jannet
AU - Heitmann, Berit L
PY - 2016/9/1
Y1 - 2016/9/1
N2 - Aims/hypothesis: The aim of this work was to assess whether neonatal levels of 25-hydroxyvitamin D (25(OH)D) are associated with risk of developing type 1 diabetes before the age of 18 years. Methods: Two large-scale studies with different designs—a case-cohort and a case–control—were conducted using Danish national register data and biobank material. Weighted Cox regression and conditional logistic regression were used to calculate HRs and ORs, respectively. The concentration of 25(OH)D was assessed from neonatal dried blood spots using highly sensitive liquid chromatography–tandem mass spectrometry. Quintiles of 25(OH)D3were used in the main analyses. Results: The case-cohort study included 912 type 1 diabetes cases and 2866 individuals without type 1 diabetes born in Denmark between 1981 and 2002 and followed up until the end of 2012. The case–control study included 527 matched case–control pairs born between 1981 and 1999 and followed up until May 2004. Both studies found no association between 25(OH)D3levels and later risk of developing type 1 diabetes. The neonatal total 25(OH)D levels in the studies were low: 46% (case-cohort study) and 51% (case–control study) of individuals had 25(OH)D levels <25 nmol/l. Conclusions/interpretation: Our two large-scale national studies showed that 25(OH)D3levels around the time of birth were not associated with later type 1 diabetes risk. Whether higher levels of 25(OH)D3during pregnancy, acquired by higher doses of supplementation than are recommended today in most countries, could protect the offspring against type 1 diabetes cannot be ruled out by the present studies.
AB - Aims/hypothesis: The aim of this work was to assess whether neonatal levels of 25-hydroxyvitamin D (25(OH)D) are associated with risk of developing type 1 diabetes before the age of 18 years. Methods: Two large-scale studies with different designs—a case-cohort and a case–control—were conducted using Danish national register data and biobank material. Weighted Cox regression and conditional logistic regression were used to calculate HRs and ORs, respectively. The concentration of 25(OH)D was assessed from neonatal dried blood spots using highly sensitive liquid chromatography–tandem mass spectrometry. Quintiles of 25(OH)D3were used in the main analyses. Results: The case-cohort study included 912 type 1 diabetes cases and 2866 individuals without type 1 diabetes born in Denmark between 1981 and 2002 and followed up until the end of 2012. The case–control study included 527 matched case–control pairs born between 1981 and 1999 and followed up until May 2004. Both studies found no association between 25(OH)D3levels and later risk of developing type 1 diabetes. The neonatal total 25(OH)D levels in the studies were low: 46% (case-cohort study) and 51% (case–control study) of individuals had 25(OH)D levels <25 nmol/l. Conclusions/interpretation: Our two large-scale national studies showed that 25(OH)D3levels around the time of birth were not associated with later type 1 diabetes risk. Whether higher levels of 25(OH)D3during pregnancy, acquired by higher doses of supplementation than are recommended today in most countries, could protect the offspring against type 1 diabetes cannot be ruled out by the present studies.
U2 - 10.1007/s00125-016-4002-8
DO - 10.1007/s00125-016-4002-8
M3 - Journal article
C2 - 27241183
SN - 0012-186X
VL - 59
SP - 1871
EP - 1881
JO - Diabetologia
JF - Diabetologia
IS - 9
ER -
